Trials / Completed
CompletedNCT00636389
Molecule Removal and Ease of Use: A Comparison of Two Different Dialyzers
Urea, Phosphate and b2-Microglobulin Removal and Ease of Use: Comparing the Polyflux HD-C4 With the Polyflux 210H
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Vantive Health LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Polyflux HD-C4 (Gambro Renal Products) is a new dialyzer based on the existing Polyflux H membrane and dialyzer technology, but which achieves a performance comparable to Polyflux 210H in a significantly smaller device. The objectives of this study are: 1. To compare and contrast small and large molecule removal by the Polyflux HD-C4 and Polyflux 210H dialyzers under conditions of routine hemodialysis; and, 2. To compare and contrast the ease of use of the Polyflux HD-C4 dialyzer with that of the Polyflux 210H under conditions of routine clinical use for hemodialysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Polyflux 210H dialyzer | Three consecutive treatments with the Polyflux 210H dialyzer. All study treatments will be performed in the standard hemodialysis mode. |
| DEVICE | Polyflux HD-C4 | Three consecutive treatments with the Polyflux HD-C4 dialyzer. All study treatments will be performed in the standard hemodialysis mode. |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2008-12-01
- Completion
- 2009-03-01
- First posted
- 2008-03-14
- Last updated
- 2025-07-14
- Results posted
- 2011-08-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00636389. Inclusion in this directory is not an endorsement.